New approval for Resflor Gold
Intervet/Schering-Plough Animal Health has announced that Resflor Gold has been approved by the FDA for the treatment of BRD associated with four major bovine respiratory pathogens.
ISPAH introduces combination treatment for BRD
Intervet/Schering-Plough Animal Health announced the introduction of Resflor Gold, the only medication on the US market that combines the antibiotic florfenicol (active ingredient in Nuflor Gold) and the non-steroidal anti-inflammatory drug.
Inflammation and behavioral changes in cattle
Animals responding to severe local or systemic inflammation will have a fever, muscle weakness, lethargy and malaise generally expressed by reluctance to move around or associate with herd mates, will groom less, will lie down more, will go off-feed and drink less, explains Dr. Mark Spire, technical services veterinarian for Intervet/Schering-Plough Animal Health.
ISPAH introduces antibiotic for four BRD pathogens
Intervet/Schering-Plough Animal Health announced the introduction of Nuflor Gold (florfenicol), an antibiotic for the treatment of bovine respiratory disease (BRD) associated with four major bovine respiratory pathogens.
New antibiotic offers dual therapy efficacy against BRD
Dramatic time-lapse video - over a six-hour period - shows a calf improving after being administered Resflor Gold.
Health and growth performance of high-risk cattle treated with Nuflor or Draxxin
In the fall of 2006, a randomized, blinded, clinical trial was performed at a commercial feedyard in Nebraska.
Nuflor is the antibiotic with five key scientific fundamentals
Cattle veterinarian recommend Nuflor, according to Internet/Schering-Plough Animal Health, because it is: a fast-acting antibiotic with bacteria-killing concentrations in lungs 30 minutes after administration; a lipophilic antibiotic that quickly penetrates healthy and diseased lung tissue; a bactericidal antibiotic proven to kill two major BRD bacteria within 24 hours; a broad-spectrum antibiotic that is effective against the major bacterial causes of BRD; and an efficacious BRD therapy with an excellent susceptibility profile.
Nuflor yields lower BRD fatality rate
In the Fall of 2007, a randomized, blinded clinical trial was performed at a commercial feedyard in Alberta, Canada.
Comparison of Florfenicol and Tulathromycin
The purpose of this study was to compare the efficacy and cost-effectiveness of florfenicol versus tulathromycin for initial treatment of undifferentiated fever in fallplaced steer calves that received metaphylactic tilmicosin on arrival at the feedlot.